Cargando…

Clinical Characteristics of Turkish Women with Candida krusei Vaginitis and Antifungal Susceptibility of the C. krusei Isolates

Objective. Candida krusei causes approximately 1% of vulvovaginal candidiasis (VVC) cases and is naturally resistant to fluconazole. Antifungal testing may be required if C. krusei vaginitis fails to respond to non-fluconazole therapy, particularly in patients with recurrent infections. Design. We i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Güzel, Ahmet Bariş, Aydın, Merve, Meral, Melda, Kalkancı, Ayşe, Ilkit, Macit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874352/ https://www.ncbi.nlm.nih.gov/pubmed/24396265 http://dx.doi.org/10.1155/2013/698736

Ejemplares similares

Cardiac Candida krusei infection
por: Wiwanitkit, Viroj
Publicado: (2010)

Promising antifungal activity of new oxadiazole against Candida krusei
por: Faria, Daniella Renata, et al.
Publicado: (2020)

Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei
por: Gong, Jie, et al.
Publicado: (2018)

Molecular Phylogenetic Analysis of Candida krusei
por: Domán, Marianna, et al.
Publicado: (2022)

Antifungal Activity and Mode of Action of Miltefosine Against Clinical Isolates of Candida krusei
por: Wu, Yongqin, et al.
Publicado: (2020)

Upregulation of the ERG11 gene in Candida krusei by azoles
por: Tavakoli, M., et al.
Publicado: (2010)

Renal allograft pyelonephritis and fungemia due to Candida krusei
por: Westervelt, Justin D., et al.
Publicado: (2014)

Case report: Candida krusei spondylitis in an immunocompromised patient
por: Overgaauw, Audrey J. C., et al.
Publicado: (2020)

Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
por: Scorzoni, Liliana, et al.
Publicado: (2013)

Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei
por: Cerqueira, Fátima, et al.
Publicado: (2021)

Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei
por: Das, Bhaskar, et al.
Publicado: (2016)

A cluster of Candida krusei infections in a haematological unit
por: Hautala, Timo, et al.
Publicado: (2007)

Risk Factors and Mortality Associated with Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2017)

Biosorption Performance of Encapsulated Candida krusei for the removal of Copper(II)
por: Luk, Chi Him Jim, et al.
Publicado: (2017)

P357 Update on risk factors for Candida krusei-Fungemia
por: Jansen, Julia C., et al.
Publicado: (2022)

Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol
por: Sachivkina, Nadezhda, et al.
Publicado: (2021)

Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience
por: Choi, Hee Kyoung, et al.
Publicado: (2009)

Prolonged Outbreak of Candida krusei Candidemia in Paediatric Ward of Tertiary Care Hospital
por: Kaur, Harsimran, et al.
Publicado: (2020)

Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells
por: Navarro-Arias, María J, et al.
Publicado: (2019)

Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5
por: Cuomo, Christina A., et al.
Publicado: (2017)

Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen
por: Gómez-Gaviria, Manuela, et al.
Publicado: (2020)

Antifungal Resistance Profile, Biofilm Formation, and Virulence Factor Production in Candida krusei Isolates From HIV-Infected Patients in Cameroon
por: Kountchou, Cyrille Levis, et al.
Publicado: (2023)

Candida krusei form mycelia along agar surfaces towards each other and other Candida species
por: Fleischmann, Jacob, et al.
Publicado: (2017)

S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares
por: Sharifzadeh, Aghil, et al.
Publicado: (2022)

The Effect of Created Local Hyperosmotic Microenvironment in Microcapsule for the Growth and Metabolism of Osmotolerant Yeast Candida krusei
por: Chen, Guo, et al.
Publicado: (2013)

Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2018)

Candida krusei infection presenting as a right ventricular mass in a two month old Infant
por: Patted, Suresh V, et al.
Publicado: (2009)

Candida krusei Empyema Thoracis: A Community-Acquired Infection Requiring a High Index of Suspicion
por: Bukamur, Hazim, et al.
Publicado: (2018)

Presence of O‐glycosidically linked oligosaccharides in the cell wall mannan of Candida krusei purified with Benanomicin A
por: Kuraoka, Takuya, et al.
Publicado: (2018)

Role of Ectopic Gene Conversion in the Evolution of a Candida krusei Pleiotropic Drug Resistance Transporter Family
por: Lamping, Erwin, et al.
Publicado: (2017)

Recombinant polymerase amplification combined with lateral flow strips for the detection of deep-seated Candida krusei infections
por: Zhao, Mengdi, et al.
Publicado: (2022)

Talus osteomyelitis by Candida krusei with multiple huge cystic lesions: a case report and review of literatures
por: Kim, Hyungtae, et al.
Publicado: (2022)

Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida
por: Hospenthal, Duane R, et al.
Publicado: (2006)

Pellicle associated adherence film above incubation broth surface - an inexpensive adjunct to recognizing Candida krusei in the laboratory
por: Fleischmann, Jacob, et al.
Publicado: (2011)

Efficacy of Pterocarpus angolensis crude extracts against Candida krusei, Staphylococcus aureus, Streptococcus agalactiae and Escherichia coli
por: Chipinga, Jones Victor, et al.
Publicado: (2018)

Post-translational modifications confer amphotericin B resistance in Candida krusei isolated from a neutropenic patient
por: Zhang, Li, et al.
Publicado: (2023)

LATE ONSET CANDIDA KRUSEI SEPTICAEMIA IN A NEONATE WHICH RESPONDED TO FLUCONAZOLE MONOTHERAPY: A CASE REPORT
por: Adigun, M.B., et al.
Publicado: (2022)

Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei
por: He, Xiaoyuan, et al.
Publicado: (2015)

Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names
por: Douglass, Alexander P., et al.
Publicado: (2018)

Enhanced Killing of Candida krusei by Polymorphonuclear Leucocytes in the Presence of Subinhibitory Concentrations of Melaleuca alternifolia and “Mentha of Pancalieri” Essential Oils
por: Tullio, Vivian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9mo9ej4q0a77nggt10ia936im7